反应详情

The title compound was prepared according to the procedure described in step 2 of Example 22 from phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate (step 1 of Example 22) and 2,4-dimethyl-1,3-thiazole-5-sulfonamide: 1H-NMR [CDCl3/CD3OD(10:1)] δ 7.46-7.22 (9H, m), 6.20 (1H, br.s), 3.48-3.45 (2H, m), 2.88-2.82 (2H, m), 2.64 (3H, s), 2.59 (3H, s), 2.30 (3H, s), 2.20 (3H, s).